11 - 18 of 18 Results
Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).
Free-standing, thin films were fabricated with a binder resulting in nearly an order of magnitude thickness decrease while increasing porosity and activation energy. These effects of such diminished significantly. Free-standing films could be fabricated with a binder.
This technology creates a light and metalless current collector for battery application. Cathodes coated on this new current collector demonstrated similar contact resistance, lower charge transfer resistance and similar or high rate performance.
There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).